~~<i id='096BDD761C'><strike id='096BDD761C'><tt id='096BDD761C'><pre id='096BDD761C'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

focus

leisure time

author：explore 2025-09-29 23:28:09 - browse：71

A green number 3 with an eye is surrounded by smaller, black number 3s on a purple background — 3 to watch coverage from STAT — Christine Kao/STAT

Life in the CRISPR lane tends to move at lightning speed. This year saw the first-ever approval of a medicine based on the gene editing technology, barely more than a decade after publication of its first demonstration by Nobel laureates Jennifer Doudna and Emmanuelle Charpentier.

The landmark decision paves the way for in vivo therapies, which edit cells inside the body, to reach patients, as well as treatments based on more efficient genome editors with fancier DNA-altering tricks up their sleeves.

Here are three CRISPR developments we’re watching in 2024:

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Hepatitis C has a cure — but many Americans still lack access to it
Next article： GOP presidential candidates start declaring their loyalty

focus

entertainment

Wikipedia

entertainment

1:30Aboywalksthroughafloodedareainal-SagainorthofOmdurmanonAugust6,2023.Torrentialrainshavedestroyed

WSS

Kim Kardashian sparks debate on benefits of full

Pharma budget tightening trickles down to Doximity

Hubble vs. James Webb telescope images: See the difference

Kim Kardashian sparks debate on benefits of full

Listen: Your guide to Wegovy's blockbuster heart study

Grandmother of French teen shot dead by police officer pleads with rioters to stop the violence

focus

leisure time

focus

Supreme Court strikes down use of affirmative action

Where are patients getting their prescriptions for GLP

DIEP, the 'gold standard' of breast reconstruction, is under threat

Correcting Robert F. Kennedy Jr.'s vaccine 'facts'

The high cost of giving birth even with insurance

Security flaws in third

Tori Bowie and the unacceptable rates of Black maternal death

A letter from the executive editor: The 2023 STATUS List

DIEP, the 'gold standard' of breast reconstruction, is under threat

The history of OxyContin, told through Purdue Pharma documents

focus

'Screen and refer' systems are hurting patients

The wait for US passports is creating travel purgatory and snarling summer plans

Who are the detained American citizens released from prison in Iran?

Security flaws in third

Genentech weighs delaying cancer therapy after drug pricing law

Dexcom's push to bring CGM to type 2 diabetes patients

entertainment

entertainment

Wikipedia

entertainment